Advances in Taiwan’s new drug development

作者:
定價:
出版單位:
出版日期:
出版類型:
所屬領域:
瀏覽次數:

加入最愛
摘要
Taiwan’s pharmaceutical industry was based primarily on generic drugs, and over the years prior to year 2000, core capabilities for the development and manufacture of generic drugs had been largely established. However, it has become increasingly difficult to foster the further growth and increase the profitability of the industry, due to the factors including: drug price-cutting policies by the National Health Insurance Bureau, export restrictions by foreign countries,....


分享至 : 用LINE傳送
上一則
2011/11/18
紡織機械之全球市場分析
下一則
2011/11/18
歐債危機暫解,第四季扣件出口持...